We occasionally publish "clusters" of articles on topics of particular interest, which may subsequently appear in a print issue. These may be linked to, among others, our investigations, to government policy or decisions, ongoing health controversies, emergency relief after natural disasters, and such like. Although it is easy to provide visual links between the separate articles in the print issue, this is harder to do on the web.

We have therefore launched this new page to help you find related articles by providing direct links. Here you will find recent clusters on rosiglitazone and MMR, for example. If you have any suggestions for what we should add please let us know.

Health symptoms during midlife

• Research: Health symptoms during midlife in relation to menopausal transition
• Editorial: Hormone therapy for menopausal symptoms
• Editorial: Can the severity of menopausal symptoms be predicted?

Epilepsy

• Practice: Diagnosis and management of the epilepsies in adults and children: summary of updated NICE guidance
• Practice: Newer drugs for focal epilepsy in adults
• A Patient's Journey: Juvenile myoclonic epilepsy

Missing data

• Editorial: Missing clinical trial data
• Research: Fate of biomedical research protocols and publication bias in France: retrospective cohort study
• Research: Publication bias: evidence of delayed publication in a cohort study of clinical research projects
• Podcast: Missing data
• Research: Compliance with mandatory reporting of clinical trial results on ClinicalTrials.gov: cross sectional study
• Research: Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis

UN meeting on non-communicable diseases, New York, 19-20 September 2011

• Analysis: Nutritional change is not a simple answer to non-communicable diseases
• Analysis: Policy options to reduce population salt intake
• Analysis: Global response to non-communicable disease
• Commentary: Politics of affordable insulin
• Commentary: Does additional benefit justify additional costs of insulin analogues?
• Editor's choice: What is health?
• Editor's choice: NCDs and the UN summit
• Feature: The prickly problem of access to insulin
• Editorial: UN meeting for non-communicable diseases
• Feature: Tar wars over smoking cessation
• Feature: UN high level meeting on non-communicable diseases: an opportunity for whom?
  
• Feature: Trans fats - chasing a global ban
• Feature: Will industry influence derail UN summit?
• Feature: Russia’s alcohol problem
• News: Food and agriculture sectors are not adequately represented at UN health summit, says report
• Observations: Seeming virtuous on chronic disease
• Blog: The final declaration for the UN summit on NCDs
• Blog: UN meeting on NCDs goes wobbly
• Blog: More on the United Nations meeting on NCDs
• Blog: UN summit in New York – a view from the sidelines
• Blog: A diary of the UN meeting on NCDs
• Blog: A diary of the UN meeting
• doc2doc: Discuss prevention versus treatment of non-communicable diseases on BMJ Group's global clinical community
• Diabetes portal

Assessing older people

• Clinical review: cognitive assessment of older people
  

• Clinical review: Assessing and helping carers of older people
• Clinical review: Fall assessment in older people
• Clinical review: Functional assessment in older people
• Observations column: Is your mum on drugs?
• Personal view: Social care homes - what the media forget to tell us
• Video: Functional assessment in older people

CFS/ME

• Editor's choice: Ending the stalemate over CFS/ME
• Feature: Dangers of research into chronic fatigue syndrome
• Commentary: Living with CFS/ME
• Commentary: Heading for a therapeutic stalemate

Non-interventional management of acute coronary syndromes

• Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial
• Editorial: Non-interventional management of acute coronary syndromes
• Practice: Oral antiplatelet agents clopidogrel and prasugrel for the prevention of cardiovascular events

Medical devices

• Editor's choice: The trouble with medical devices
• Feature: Out of joint - the story of the ASR
• Feature: Europeans are left to their own devices
• Analysis: Medical device recalls and transparency in the UK
• Editorial: The regulation of medical devices
• Research from BMJ Open: Medical device recalls in the UK and the device regulation process
• Commentary: Evaluating and regulating device therapy
• Commentary: Use of registries to investigate the past and develop the future
• Commentary: International collaboration needed on device clinical standards
• Commentary: Metal on metal hips
• Commentary: The risk of over-regulation
• Cardiologists call for a single European system to oversee medical devices

Rheumatoid arthritis

• Editorial: Treating inflammatory arthritis early
• Clinical review: Recent advances in the management of rheumatoid arthritis
• A patient's journey: Rheumatoid arthritis
• Personal view: Outpatient follow-up ratio targets make no sense
• Personal view: Rheumatoid arthritis: young, sick, and in need of support
• Clinical review: Diagnosis and management of juvenile idiopathic arthritis

Contraceptive pills and venous thromboembolism

• Risk of non-fatal venous thromboembolism in women using oral contraceptives containing drospirenone compared with women using oral contraceptives containing levonorgestrel: case-control study using United States claims data
• Risk of venous thromboembolism in users of oral contraceptives containing drospirenone or levonorgestrel: nested case-control study based on UK General Practice Research Database
• Editorial: The risk of deep venous thrombosis with oral contraceptives containing drospirenone

Shared decision making

• Feature: Welcome to the century of the patient
• Observations: Power to the people
• Analysis: Salzburg statement on shared decision making
• Review of the week: Dare to know: risk illiteracy and shared decision making
• Editorial: Supporting patients to make the best decisions
• BMJ round table - shared decision making (full version)
• BMJ round table - shared decision making (summary)

Emergency relief/earthquake and tsunami in Japan

• Ryuki Kassai: Fukushima, one month on
• Observations: Fukushima - lightening the darkness for next time
• Ryuki Kassai: Update from Fukushima (blog)
• YouTube video live from Fukishima
• Cheryl Rofer: Reading Fukushima status reports
• Cheryl Rofer on the nuclear reactors damaged in the Japanese earthquake
• Medicine and the Media: Panic about nuclear apocalypse overshadows Japan's real plight
• News: Death toll climbs and healthcare needs escalate in Japan
• Ryuki Kassai blogs from Fukushima
• Podcast interview from Japan with Ryuki Kassai
• Japan calls on troops to help relief efforts after devastating earthquake
• Responding to disasters
• Mental health in disaster settings
• Needs assessment of humanitarian crises
• Natural disasters
• Humanitarian assistance: standards, skills, training, and experience
• Public health in the aftermath of disasters
• Military approach to medical planning in humanitarian operations
• The special needs of children and women
• Psychological aspects of providing medical humanitarian aid
• Aid after disasters
• Appropriate response to humanitarian crises
• Sharing evidence on humanitarian relief

Alcohol consumption and cardiovascular outcomes

• Research: Association of alcohol consumption with selected cardiovascular disease outcomes: systematic review and meta-analysis
• Research: Effect of alcohol consumption on biological markers associated with risk of coronary heart disease: systematic review and meta-analysis of interventional studies
• Editor's choice: Drinking - messages for the beer mat
  
• Minimum alcohol pricing in England
• A patient's journey: Alcoholism
• Podcast: A hearty drink

Secrets of the MMR scare

• Secrets of the MMR scare, part 1: how the case against the MMR vaccine was fixed
• Secrets of the MMR scare, part 2: How the vaccine crisis was meant to make money
• Secrets of the MMR scare, part 3: The Lancet's two days to bury bad news
• Editorial: Wakefield's article linking MMR vaccine and autism was fraudulent
• Blog: Piltdown medicine - the missing link between MMR and autism
• Blog: Does the Wakefield et al case mean we should demand public access to raw data?
• Student BMJ: The MMR story so far - a comic strip
• Podcast: Brian Deer discusses his features
• Editorial: Institutional research misconduct
• Feature: Pathology reports solve "new bowel disease" riddle
• Letter: Who saw the "histological findings"?
• Letter: Amar Dhillon replies to "Pathology reports solve 'new bowel disease' riddle"
• Commentary: Commentary: We came to an overwhelming and uniform opinion that these reports do not show colitis
• Commentary: Commentary: I see no convincing evidence of "enterocolitis," "colitis," or a "unique disease process"
• Editor's choice: Welcome to the new design

The problem of orphan drugs

• Open letter to prime minister David Cameron and health secretary Andrew Lansley
• Editorial: The problem of orphan drugs
• Editor's choice: Stop exploiting orphan drugs
• Feature: Drug regulation - what makes an orphan drug?
• Orphan drug pricing may warrant a competition law investigation

Rosiglitazone - what went wrong?

• Investigation: Rosiglitazone: what went wrong?
• Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones?
• Editorial: Licensing drugs for diabetes
• Editor's choice: Rosiglitazone - a cautionary tale

The truth about Tamiflu?

• Research: Neuraminidase inhibitors for preventing and treating influenza in healthy adults: systematic review and meta-analysis
• Feature: Complications - tracking down the data on oseltamivir
• Analysis: Neuraminidase inhibitors - the story behind the Cochrane review
• What can we learn from observational studies of oseltamivir to treat influenza in healthy adults?
• Roche replies to the authors of the Cochrane review on oseltamivir
• Roche's point-by-point response to BMJ questions
• Editor's choice: We want raw data, now
• Feature: Search for evidence goes on
• Analysis: Rethinking credible evidence synthesis
• News: Questions remain over safety and effectiveness of oseltamivir